Tuesday, November 12th, 2024

Omega Diagnostics Group (ODX) Receives “Corporate” Rating from FinnCap


29 January 2019  

Time taken to read : < 1 Minute


  • A
  • A
  • A

LONDON: Omega Diagnostics Group (LON:ODX)‘s stock had its “corporate” rating reiterated by stock analysts at FinnCap in a report issued on Tuesday.

ODX stock opened at GBX 13.25 ($0.17) on Tuesday. Omega Diagnostics Group has a 12 month low of GBX 15 ($0.20) and a 12 month high of GBX 28.01 ($0.37).

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other.

The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases.

Publish Date : 29 January 2019 15:59 PM

Rabi Lamichhane being taken to Rupandehi for statement

POKHARA: Rabi Lamichhane, Chairman of the Rastriya Swatantra Party (RSP),

15 UML leaders leaving for China today

KATHMANDU: Fifteen leaders of the ruling CPN-UML are leaving for

Westerly, local winds influencing Nepal’s weather conditions

KATHMANDU: The Weather Forecast Division has reported that westerly winds

Today’s foreign currency exchange rates

KATHMANDU: The value of the US dollar and the Bahraini

Economic Digest: Nepal’s Business News in a Snap

KATHMANDU: Economic Digest offers a concise yet comprehensive overview of